Cash allocation based on cash on hand equivalent to 2.0 months of monthly sales
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2024: 4 of 38 companies on the "Worse" side.
23 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Our group considers cash on hand equivalent to approximately 2.0 months of monthly sales to be the level required for stable operations. Any excess is allocated to strengthening research and development and to strategic investments that contribute to enhancing corporate value.」
The company continues to maintain a policy of using cash on hand equivalent to approximately 2.0 months of monthly sales as the benchmark and allocating excess funds to research and development and strategic investments. - FY2024First statedAnnual report
「Our group considers cash on hand equivalent to approximately 2.0 months of monthly sales to be the level required for stable operations. Any excess is allocated to strengthening research and development and to strategic investments that contribute to enhancing corporate value.」
The company has specified a cash management policy under which cash on hand equivalent to approximately 2.0 months of monthly sales is maintained for stable operations, with excess funds allocated to research and development and strategic investments.